WROCŁAW, Poland--(BUSINESS WIRE)--Infermedica, the AI-based platform for preliminary diagnosis and triage, announced it has raised $10.25 million in Series A funding. The round was led by the European Bank for Reconstruction and Development (EBRD) and digital health fund Heal Capital, with participation from existing investors Karma Ventures, Inovo Venture Partners, and Dreamit Ventures. The investment will be used for platform R&D to further enhance patient triage and symptom checking feat.